The Role of the Noradrenergic System in the Nonmotor Symptoms of Parkinson's Disease
NCT04346394
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
COVID-19
Conditions
Parkinson Disease
Interventions
DRUG:
Yohimbine HCl
Sponsor
Nathaniel M. Robbins